3.21 Affirmative Action with Leah Litman, Cost Implications with Dr. DeMartino, & Dr. John Mandrola

First up this week we interview constitutional law scholar Leah Litman, an Assistant Professor of Law at the University of Michigan, on Dr. Norman Wang and the intricacies of the laws on affirmative action. Next, we talk with Dr. Patrick DeMartino, a pediatric hematology/oncology fellow at Oregon Health & Science University, on his new paper out now in JAMA Internal Medicine: "Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018". Finally, we sit down with Dr. John Mandrola for an in-depth discussion on the intersection of medicine, politics, and advocacy.

Cost Implications: doi.org/10.1001/jamainternmed.2020.5921

Back us on Patreon! www.patreon.com/plenarysession

Vinay Prasad
HemeOnc Doctor & Associate Professor
Host of Plenary Session Podcast
  / plenarysession  
Twitter @vprasadmdmph